{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:02:20Z","timestamp":1793512940640,"version":"4.5.0"},"reference-count":36,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2012,5,7]],"date-time":"2012-05-07T00:00:00Z","timestamp":1336348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:sec>\n                    <jats:label\/>\n                    <jats:p>Study Type \u2013 Therapy (case series)<\/jats:p>\n                    <jats:p>Level of Evidence\u20034<\/jats:p>\n                    <jats:p>\n                      <jats:bold>What's known on the subject? and What does the study add?<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>Endoscopic management of small, low\u2010grade, non\u2010invasive upper tract urothelial cell carcinoma (UTUC) is a management option for selected groups of patients. However, the long\u2010term survival outcomes of endoscopically\u2010managed UTUC are uncertain because only four institutions have reported outcomes of more than 40 patients beyond 50 months of follow\u2010up. Moreover, there is significant variance in the degree of underlying UTUC pathology verification in some of these reports, which precludes an analysis of disease\u2010specific survival outcomes.<\/jats:p>\n                    <jats:p>The present study represents one of the largest endoscopically managed series of patients with UTUC, with a long\u2010term follow\u2010up. The degree of verification of underlying UTUC pathology is one of the highest, which allows a grade\u2010stratified analysis of different outcomes, including upper\u2010tract recurrence\u2010free survival, intravesical recurrence\u2010free survival, renal unit survival and disease\u2010specific survival. These outcomes provide further evidence suggesting that endoscopic management of highly selected, low\u2010grade UTUC can provide effective oncological control, as well as renal preservation, in experienced centres.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>To report the long\u2010term outcomes of patients with upper tract urothelial cell carcinoma (UTUC) who were treated endoscopically (either via ureteroscopic ablation or percutaneous resection) at a single institution over a 20\u2010year period.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>Departmental operation records were reviewed to identify patients who underwent endoscopic management of UTUC as their primary treatment.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Outcomes were obtained via retrospective analysis of notes, electronic records and registry data.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Survival outcomes, including overall survival (OS), UTUC\u2010specific survival (disease\u2010specific survival; DSS), upper\u2010tract recurrence\u2010free survival, intravesical recurrence\u2010free survival, renal unit survival and progression\u2010free survival, were estimated using Kaplan\u2013Meier methods and grade\u2010stratified differences were analyzed using the log\u2010rank test.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>Between January 1991 and April 2011, 73 patients underwent endoscopic management of UTUC with a median age at diagnosis of 67.7 years.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            All patients underwent ureteroscopy and biopsy\u2010confirmation of pathology was obtained in 81% (\n                            <jats:italic>n<\/jats:italic>\n                            = 59) of the patients. In total, 14% (\n                            <jats:italic>n<\/jats:italic>\n                            = 10) of the patients underwent percutaneous resection.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Median (range; mean) follow\u2010up was 54 (1\u2013223; 62.8) months.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Upper tract recurrence occurred in 68% (\n                            <jats:italic>n<\/jats:italic>\n                            = 50). Eventually, 19% (\n                            <jats:italic>n<\/jats:italic>\n                            = 14) of the patients proceeded to nephroureterectomy.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The estimated OS and DSS were 69.7% and 88.9%, respectively, at 5 years, and 40.3% and 77.4%, respectively, at 10 years. The estimated mean and median OS times were 119 months and 107 months, respectively. The estimated mean DSS time was 190 months.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>The present study represents one of the largest reported series of endoscopically\u2010managed UTUC, with high pathological verification and long\u2010term follow\u2010up.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Upper\u2010tract recurrence is common, which mandates regular ureteroscopic surveillance.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>However, in selected patients, this approach has a favourable DSS, with a relatively low nephroureterectomy rate, and therefore provides oncological control and renal preservation in patients more likely to die eventually from other causes.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2012.11169.x","type":"journal-article","created":{"date-parts":[[2012,5,7]],"date-time":"2012-05-07T08:59:56Z","timestamp":1336381196000},"page":"1608-1617","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Long\u2010term endoscopic management of upper tract urothelial carcinoma: 20\u2010year single\u2010centre experience"],"prefix":"10.1111","volume":"110","author":[{"given":"Mark L.","family":"Cutress","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant D.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Wells\u2010Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Tolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20073"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67019-X"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.12.042"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05402.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24135"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.03.072"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.03.003"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2011.0223"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70803-8"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.09.077"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.09.017"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.12.030"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.11.087"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11068.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.01.006"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.11.018"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2006.9922"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65273-X"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.06801.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2007.9853"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eursup.2008.12.004"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65854-3"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)64793-1"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)00043-X"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(02)00220-8"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2008.0251"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67970-0"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.10.076"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35473-3"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)68157-6"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.02.005"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.1999.13.289"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.07535.x"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2010.0276"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.12.034"},{"key":"e_1_2_7_37_2","unstructured":"BAUS.British Association of Urological Surgeons UTTCC Audit. Available at:http:\/\/www.baus.org.uk\/Sections\/endourology\/research\u2010and\u2010audit\/audits\/uttcc\u2010audit. Accessed January 2012"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2012.11169.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2012.11169.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:20:49Z","timestamp":1761758449000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2012.11169.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,7]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1464-410X.2012.11169.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2012.11169.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,7]]},"assertion":[{"value":"2012-05-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}